Key result
Adding right coronary artery pericoronary adipose tissue attenuation to a clinical model significantly improved the prediction of atrial fibrillation recurrence at 1 year (AUC 0.724 vs 0.686, p=0.024).
Why the study?
Inflammation plays a vital role in AF occurrence and progression, but the association between pericoronary adipose tissue attenuation and AF recurrence following ablation has not been fully clarified.
Does pericoronary adipose tissue attenuation predict atrial fibrillation recurrence in patients undergoing their first radiofrequency catheter ablation?
Cohort
Does pericoronary adipose tissue attenuation predict atrial fibrillation recurrence in patients undergoing their first radiofrequency catheter ablation?
p-value: p=0.024
Pericoronary adipose tissue attenuation of the right coronary artery on pre-procedural CT is an independent predictor of atrial fibrillation recurrence after radiofrequency catheter ablation.
May refine post-ablation AF recurrence risk stratification; hypothesis-generating and requires prospective validation before clinical use.
BACKGROUND: Inflammation plays a vital role in the occurrence and progression of atrial fibrillation (AF). The association between pericoronary adipose tissue attenuation (PCATA) and AF recurrence following ablation has not been fully clarified. HYPOTHESIS: We aimed to evaluate the association between PCATA and AF recurrence after radiofrequency catheter ablation (RFCA). METHODS: Patients who underwent the first RFCA for AF and performed coronary computed tomography angiography before ablation between 2018 and 2021 were enrolled. The predictive values of PCATA for AF recurrence after ablation were investigated. The area under curve (AUC), relative integrated discrimination improvement (IDI), and categorical free net reclassification improvement (NRI) were used to assess the discrimination ability of different models for AF recurrence. RESULTS: During 1-year follow-up, 34.1% patients experienced AF recurrence. The multivariable analysis model revealed that PCATA of the right coronary artery (RCA) was an independent risk factor for AF recurrence. Patients with a high level of RCA-PCATA had a high risk of recurrence, after adjusting for other risk factors by restricted cubic splines. The performance in predicting AF recurrence was significantly improved by adding the marker of RCA-PCATA to the clinical model (AUC: 0.724 vs. 0.686, p = .024), with a relative IDI of 0.043 (p = .006) and continuous NRI of 0.521 (p < .001). CONCLUSIONS: PCATA of RCA was independently associated with AF recurrence after ablation. PCATA may be helpful for risk classification for AF ablation patients.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2023) conducted a cohort in Atrial fibrillation. Pericoronary adipose tissue attenuation (PCATA) vs. Clinical model without PCATA / Low PCATA was evaluated on Atrial fibrillation recurrence (p=0.024). Adding right coronary artery pericoronary adipose tissue attenuation to a clinical model significantly improved the prediction of atrial fibrillation recurrence at 1 year (AUC 0.724 vs 0.686, p=0.024).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: